About
Professor Mandana Nikpour is a leading academic in rheumatology and public health at the University of Sydney, holding the titles of Director of the Sydney MSK Research Flagship Centre and Professor of Public Health at the Sydney School of Public Health. She is also the Executive Chair of the Australian Scleroderma Interest Group and Principal Investigator of the Asia-Pacific Lupus Collaboration. Her expertise spans systemic lupus erythematosus (SLE), systemic sclerosis (scleroderma), and autoimmune disease management.
Education: MBBS, FRACP (Royal Australasian College of Physicians), FRCPA (Royal College of Pathologists of Australasia), PhD, and FAHMS (Fellow of the Australian Academy of Health and Medical Sciences).
Research focuses on improving clinical outcomes for autoimmune diseases, including disease activity measurement, treatment strategies, and understanding pathophysiological mechanisms. Key areas include SLE and systemic sclerosis epidemiology, immunosuppressant use, and the impact of multimorbidity. Her work integrates interdisciplinary approaches, such as biomarker development and public health policy.
Publications emphasize systematic reviews, meta-analyses, and cohort studies addressing treatment efficacy, disease progression, and healthcare economics. Notable contributions include defining core outcome sets for SLE trials and validating damage indices in systemic sclerosis.
Advising: Supervises Lucinda ROPER on understanding systemic lupus and sclerosis distribution in Australia. Collaborates with global networks like the Asia-Pacific Lupus Collaboration and OMERACT to advance clinical standards.
Labs/Teams: Leads the Sydney MSK Research Flagship Centre, focusing on musculoskeletal and autoimmune research, and drives initiatives through the Australian Scleroderma Interest Group.
